Current Investments
CrossBridge Bio, Inc. - Next-generation antibody drug conjugates
AlmataBio, Inc. - Asset centric company focused on biologics for inflammation
Prior Ventures
ValenzaBio, Inc. (acquired in 2023 by Acelyrin)
Ichorion Therapeutics, Inc. (acquired in 2018 by Cerecor)